Similarly, in vitro studies, it was found that overexpression of PHLPP1 inhibited EGFR-TKI resistance in non-small cell lung cancer via the MAPK/ERK pathway (20, 21). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.